Danaher Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Danaher de 13.5% y 6.4% por año respectivamente. Se prevé que el BPA crezca en un 13.4% al año. Se espera que la rentabilidad financiera sea de 10.6% en 3 años.

Información clave

13.5%

Tasa de crecimiento de los beneficios

13.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Life Sciences	16.7%
Tasa de crecimiento de los ingresos	6.4%
Rentabilidad financiera futura	10.6%
Cobertura de analistas	Good
Última actualización	24 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Sep 30

Danaher: A Lost Year

Aug 30

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Aug 02

Danaher: A Compounding Icon At A Fair Price

Jul 25

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Jul 13

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Jun 28

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Jun 22

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Jun 15

Danaher: A Great Chance To Buy This Long-Term Compounder

May 23

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Apr 26

Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Mar 28

Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

Mar 15

Is Danaher (NYSE:DHR) Using Too Much Debt?

Mar 02

Danaher ups dividend by 8% to $0.27

Feb 22

Danaher Q4 2022 Earnings Preview

Jan 23

Does Danaher (NYSE:DHR) Deserve A Spot On Your Watchlist?

Jan 16

We Have A Winner! Revisiting Danaher And Thermo Fisher

Jan 11

Danaher downgraded to neutral at Credit Suisse on exposure to inventory reductions

Jan 05

A Look At The Fair Value Of Danaher Corporation (NYSE:DHR)

Dec 18

Danaher: A Great Business - The Price Where I Would Buy

Dec 14

Danaher declares $0.25 dividend

Dec 06

When Should You Buy Danaher Corporation (NYSE:DHR)?

Dec 04

Does Danaher (NYSE:DHR) Have A Healthy Balance Sheet?

Nov 20

Previsiones de crecimiento de beneficios e ingresos

NYSE:DHR - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	28,070	5,932	6,803	8,038	15
12/31/2025	26,007	5,385	6,342	7,616	24
12/31/2024	23,904	4,442	5,625	6,645	22
3/29/2024	23,737	4,069	5,548	6,956	N/A
12/31/2023	23,890	4,200	5,781	7,164	N/A
9/29/2023	23,520	4,783	6,819	8,086	N/A
6/30/2023	24,310	5,205	7,245	8,424	N/A
3/31/2023	24,904	5,757	7,364	8,498	N/A
12/31/2022	26,643	6,222	7,401	8,519	N/A
9/30/2022	31,250	6,640	7,068	8,311	N/A
7/1/2022	30,816	6,206	7,051	8,335	N/A
4/1/2022	30,283	6,206	7,162	8,455	N/A
12/31/2021	24,802	5,283	7,118	8,358	N/A
10/1/2021	28,065	5,636	7,056	8,246	N/A
7/2/2021	26,720	5,361	6,876	7,935	N/A
4/2/2021	24,799	4,595	6,351	7,260	N/A
12/31/2020	22,284	3,510	5,417	6,208	N/A
10/2/2020	20,392	3,083	4,444	5,099	N/A
7/3/2020	18,886	2,853	3,712	4,341	N/A
4/3/2020	18,034	2,614	3,439	4,068	N/A
12/31/2019	17,911	2,364	3,316	3,952	N/A
9/27/2019	15,562	2,093	3,479	4,078	N/A
6/28/2019	16,037	2,145	3,446	4,032	N/A
3/29/2019	16,573	2,166	3,311	3,896	N/A
12/31/2018	17,049	2,406	3,438	4,022	N/A
9/28/2018	19,615	2,761	3,004	3,619	N/A
6/29/2018	19,290	2,669	3,167	3,772	N/A
3/30/2018	18,819	2,553	3,148	3,747	N/A
12/31/2017	15,519	2,172	N/A	3,478	N/A
9/29/2017	17,828	2,360	N/A	3,292	N/A
6/30/2017	17,432	2,191	N/A	3,038	N/A
3/31/2017	17,164	2,051	N/A	3,309	N/A
12/31/2016	16,882	2,153	N/A	3,522	N/A
9/30/2016	16,621	1,927	N/A	4,104	N/A
7/1/2016	16,001	1,905	N/A	4,239	N/A
4/1/2016	13,663	1,775	N/A	4,051	N/A
12/31/2015	14,434	1,747	N/A	3,802	N/A
10/2/2015	15,335	1,875	N/A	3,810	N/A
7/3/2015	16,530	2,177	N/A	3,873	N/A
4/3/2015	19,186	2,521	N/A	3,771	N/A
12/31/2014	12,867	1,639	N/A	3,758	N/A
9/26/2014	19,197	2,683	N/A	3,597	N/A
6/27/2014	19,159	2,599	N/A	3,553	N/A
3/28/2014	19,336	2,583	N/A	3,460	N/A
12/31/2013	18,283	2,591	N/A	3,585	N/A
9/27/2013	18,827	2,536	N/A	3,307	N/A
6/28/2013	18,573	2,488	N/A	3,297	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (13.5% al año) de DHR es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (13.5% al año) de DHR crezcan menos que el mercado US (14.6% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de DHR crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (6.4% al año) de DHR crezcan más despacio que el mercado de US (8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 6.4% al año) de DHR crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de DHR sea baja dentro de 3 años (10.6%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Danaher Crecimiento futuro

Future controles de criterios 1/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates fall by 11%

Danaher Corporation Provides Earnings Guidance for the Fourth Quarter 2023

Consensus EPS estimates fall by 10%

Danaher Corporation Revises Revenue Guidance for the Fourth Quarter of 2022

Recent updates

Value Vs. Growth? Danaher Says Why Not Both?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Danaher: All In On Life Sciences, And Market Update

Danaher Corporation to Report Q1, 2024 Results on Apr 23, 2024

Upcoming dividend of US$0.27 per share

Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?

Insider notifies of intention to sell stock

Dividend of US$0.27 announced

Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on April 26, 2024

Danaher Corporation, Annual General Meeting, May 07, 2024

Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings

Consensus EPS estimates fall by 11%

Full year 2023 earnings: EPS and revenues miss analyst expectations

Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term

Now 20% overvalued after recent price rise

Is Danaher (NYSE:DHR) Using Too Much Debt?

Danaher Corporation Provides Earnings Guidance for the Fourth Quarter 2023

My Top 2024 Stock Pick: Danaher

Danaher Corporation to Report Q4, 2023 Results on Jan 30, 2024

Upcoming dividend of US$0.24 per share at 0.5% yield

Danaher Corporation (NYSE:DHR) completed the acquisition of Abcam plc (NasdaqGS:ABCM).

Danaher Corporation Announces Quarterly Dividend, Payable on January 26, 2024

Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles

RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing

Why Danaher Is One Of My Favorite Long-Term Investments

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Consensus EPS estimates fall by 10%

Danaher: Short-Term Headwinds, But Long-Term Tailwinds

Now 20% undervalued after recent price drop

Upcoming dividend of US$0.27 per share at 0.5% yield

Danaher Corporation completed the Spin-Off of Veralto Corporation (NYSE:VLTO.WI).

Should Danaher Investors Sell New Veralto Shares?

Danaher Corporation's (NYSE:DHR) Intrinsic Value Is Potentially 18% Below Its Share Price

Danaher Corporation to Report Q3, 2023 Results on Oct 24, 2023

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund At Cost

Danaher Corporation Announces Quarterly Cash Dividend, Payable on October 27, 2023

Danaher: A Lost Year

Danaher Corporation (NYSE:DHR) entered into definitive agreement to acquire Abcam plc (NasdaqGS:ABCM) for $5.7 billion.

Levi & Korsinsky Notifies Danaher Corporation Investors of A Class Action Lawsuit and Upcoming Deadline

New minor risk - Insider selling

Lead Independent Director recently sold US$1.9m worth of stock

Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens

Executive Vice President notifies of intention to sell stock

Second quarter 2023 earnings: EPS misses analyst expectations

Danaher: A Compounding Icon At A Fair Price

Pomerantz LLP Announces Filing of Class Action Against Danaher Corporation

These 4 Measures Indicate That Danaher (NYSE:DHR) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Danaher Corporation(NYSE:DHR) dropped from Russell 1000 Growth Index

Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump

Upcoming dividend of US$0.27 per share at 0.5% yield

Danaher Corporation to Report Q2, 2023 Results on Jul 25, 2023

At US$238, Is It Time To Put Danaher Corporation (NYSE:DHR) On Your Watch List?

Insider notifies of intention to sell stock

Danaher: A Great Chance To Buy This Long-Term Compounder

Danaher Corporation Approves Regular Quarterly Cash Dividend, Payable on July 28, 2023

Executive Vice President exercised options and sold US$1.9m worth of stock

Senior VP & Chief Science Officer recently sold US$121k worth of stock

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

With EPS Growth And More, Danaher (NYSE:DHR) Makes An Interesting Case

Co-Founder & Chairman exercised options to buy US$32m worth of stock.

Estimating The Intrinsic Value Of Danaher Corporation (NYSE:DHR)

Upcoming dividend of US$0.27 per share at 0.4% yield

Is Now The Time To Look At Buying Danaher Corporation (NYSE:DHR)?

Is Danaher (NYSE:DHR) Using Too Much Debt?

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Danaher ups dividend by 8% to $0.27

Veralto Corporation Announces Management Appointments

Danaher Reportedly Expresses Takeover Interest in Catalent

Independent Director exercised options and sold US$1.4m worth of stock

Full year 2022 earnings: EPS and revenues exceed analyst expectations